Prognostic value of MRI volumetric parameters in non-small cell lung cancer patients after immune checkpoint inhibitor therapy: comparison with response assessment criteria

MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy

(2022) Johanna Heugenhauser et al.   Cancers

Tumor response assessment on imaging following immunotherapy

(2022) Antonia M. Berz et al.   Frontiers in Oncology

A Comparative Retrospective Study of Immunotherapy RANO Versus Standard RANO Criteria in Glioblastoma Patients Receiving Immune Checkpoint Inhibitor Therapy

(2021) Xin Chen et al.   Frontiers in Oncology

Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial

(2020) Sarah B Goldberg et al.   LANCET ONCOLOGY

Dissociated Response in Metastatic Cancer: An Atypical Pattern Brought Into the Spotlight With Immunotherapy

(2020) Olivier Humbert et al.   Frontiers in Oncology

Novel patterns of response under immunotherapy

(2019) E Borcoman et al.   ANNALS OF ONCOLOGY

Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study

(2019) Philipp Kickingereder et al.   LANCET ONCOLOGY

Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: Response, Progression, and Pseudoprogression

(2019) Norbert Galldiks et al.   NEURO-ONCOLOGY

CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non–Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3)

(2018) Yi-Long Wu et al.   JOURNAL OF CLINICAL ONCOLOGY

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain

(2018) Hussein A. Tawbi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparing available criteria for measuring brain metastasis response to immunotherapy

(2017) Jack M. Qian et al.   JOURNAL OF NEURO-ONCOLOGY

Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab—a report from the BELOB trial

(2017) Renske Gahrmann et al.   NEURO-ONCOLOGY

Immunotherapy response assessment in neuro-oncology: a report of the RANO working group

(2015) Hideho Okada et al.   LANCET ONCOLOGY

Response assessment criteria for brain metastases: proposal from the RANO group

(2015) Nancy U Lin et al.   LANCET ONCOLOGY

Semiautomated Volumetric Measurement on Postcontrast MR Imaging for Analysis of Recurrent and Residual Disease in Glioblastoma Multiforme

(2013) D.S. Chow et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

The Medical Imaging Interaction Toolkit: challenges and advances

(2013) Marco Nolden et al.   International Journal of Computer Assisted Radiology and Surgery

Stereotactic Radiosurgery for the Management of Brain Metastases

(2010) John H. Suh   NEW ENGLAND JOURNAL OF MEDICINE

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER